Gut-Brain-Axis/Lung-Brain-Axis and Mental Ill Health in Critical Illness
NCT ID: NCT05580367
Last Updated: 2023-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2023-02-14
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Evidence shows the existence of a two-way, communication network between gut microbes and the brain referred to as the gut-brain axis. Changes in the microbiome and dysregulation of this communication network in relatively healthy people is associated with cognitive dysfunction and mood disorders such as anxiety and depression. The physiological stress associated with critical illness itself and many ICU interventions including the use of mechanical ventilation and medications such as antibiotics, antacids, vasopressors, and steroids can influence the balance of the gut microbiome and associated metabolites.
This observation study aims to:
1. Quantify and measure dynamic changes in the gut microbiome and its metabolites during critical illness and recovery.
2. Explore the associations between microbiome and metabolomic changes during critical illness and psychological symptoms in the patient during their recovery.
This knowledge will provide the potential to create interventions that alter the gut environment and microbiome both during and following a critical illness in order to reduce long-term adverse psychological effects. Examples of such potential interventions include dietary modifications with the use of prebiotics or probiotics.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
NCT05357170
Long-term Follow up in Survivors of Critical Illness
NCT04608994
Prospective Evaluation of Psychological Consequences and Impact on Long-term Quality of Life
NCT06238557
Can a Patient in Intensive Care be Visited by His or Her Pet?
NCT06121050
The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units?
NCT06749483
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged ≥18 years old
* Requiring mechanical ventilation
* Commencing ventilation within the previous 24 hours
* Expected to be ventilated for minimum of ≥72 hours
Exclusion Criteria
* Known prior mental ill health
* Known malignancy
* Admitted after presenting with any of the following conditions:
* trauma
* brain injury
* surgery
* cardiac arrest
* immunosuppressed
* underlying pyogenic infection
* Not expected to survive to completion of the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Southampton NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Southampton NHS Foundation Trust
Southampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rebecca Cusack
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RHM CRI0428
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.